Effects and implications of the COVID-19 pandemic on medicine use by employees of a Brazilian public university
a cross-sectional study
Keywords:
Drug utilization, COVID-19, Universities, Faculty, PharmacoepidemiologyAbstract
BACKGROUND: During the COVID-19 pandemic, universities have had to adopt remote education, a strategy that caused sudden changes of routine for everyone involved in academia. OBJECTIVE: To assess the profile of medicine use by the employees of a Brazilian public university during the COVID-19 pandemic. DESIGN AND SETTING: Cross-sectional study at a Brazilian public university. METHODS: Employees were invited to answer an online self-administered questionnaire, containing questions on sociodemographic features, medicine use, mental health and lifestyle habits during the COVID-19 pandemic. The outcome variable was the use of medicines stratified according to occupation. Descriptive, bivariate and multivariate (Poisson regression) statistical analyses were performed. RESULTS: A total of 372 employees participated in the study and use of medicine was reported by 53.2%. Among professors, suicide attempts (prevalence ratio [PR], 1.81; 95% confidence interval [CI], 1.20-2.74), physical activity (PR, 1.53; 95% CI, 1.11-2.11) and poor self-rated health (PR, 1.29; 95% CI, 1.01-1.66); and among technicians, decreased workload during the COVID-19 pandemic (PR, 1.41; 95% CI, 1.00-1.99), excess body weight (PR, 1.39; 95% CI, 1.02-1.88) and poor self-rated health (PR, 1.48; 95% CI, 1.14-1.92) werepositively associated with use of medicines. In addition, among technicians, engaging in physical activity (PR, 0.60; 95% CI, 0.46-0.78) was a protective factor against medicine use. CONCLUSION: The profile of medicine use among these employees was similar to that of the Brazilian population. However, some associated factors may have been influenced by the COVID-19 pandemic, thus highlighting the need to examine this topic in a longitudinal study.
Downloads
References
Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-60. PMID: 32191675; https://doi.org/10.23750/abm.v91i1.9397
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. PMID: 31978945; https://doi.org/10.1056/NEJMoa2001017
Ministério da Saúde, Brasil. Boletins Epidemiológicos. 2021. Available from: https://www.gov.br/saude/pt-br/assuntos/boletins-epidemiologicos Accessed in 2021 (Mar 18)
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931-4. PMID: 32164834; https://doi.org/10.1016/S0140-6736(20)30567-5
Organização Pan-americana da Saúde - OPAS. Folha informativa sobre COVID-19. 2020. Available from: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&I%20temid=875. Accessed in 2021 (Jul 26).
Gusso HL, Archer AB, Luiz FB, et al. Ensino superior em tempos de pandemia: diretrizes à gestão universitária. Educ Soc. 2020;41:e238957. https://doi.org/10.1590/es.238957
Faro A, Bahiano MdA, Nakano TdC, et al. COVID-19 e saúde mental: a emergência do cuidado. Estud Psicol. 2020;37:e200074. https://doi.org/10.1590/1982-0275202037e200074
Hodges C, Moore S, Lockee B, Trust T, Bond A. The Difference Between Emergency Remote Teaching and Online Learning. 2020. Available from: https://er.educause.edu/articles/2020/3/the-difference-between-emergency-remote-teaching-and-online-learning Accessed 2021 (Mar 2).
Conselho Federal de Farmácia - CFF. Venda de medicamentos psiquiátricos cresce na pandemia. 2020. Available from: http://covid19.cff.org.br/venda-de-medicamentos-psiquiatricos-cresce-na-pandemia/ Accessed in 2021 (Mar 2).
Universidade Federal de Ouro Preto - UFOP. UFOP em números. 2020. Available from: https://ufop.br/ufop-em-numeros Accessed in 2021 (Mar 18).
Who Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. 2021. Available from: https://www.whocc.no/atc_ddd_index/ Accessed in 2021 (Mar 18).
The World Bank. PPP conversion factor. 2019. Available from: https://data.worldbank.org/indicator/PA.NUS.PPP Accessed in 2021 (Mar 2).
Brasil. Constituição da República Federativa do Brasil: promulgada em 5 de outubro de 1988. 1988. Available from: https://www.senado.leg.br/atividade/const/con1988/CON1988_05.10.1988/CON1988.asp Accessed in 2021 (Mar 2).
Brasil. Lei nº 10.406, de 10 de janeiro de 2002. Institui o Código Civil. 2002. Available from: http://www.planalto.gov.br/ccivil_03/leis/2002/L10406compilada.htm Accessed in 2021 (Mar 2).
Bertoldi AD, Pizzol TD, Ramos LR, et al. Sociodemographic profile of medicines users in Brazil: results from the 2014 PNAUM survey. Rev Saude Publica. 2016;50(suppl 2):5s. PMID: 27982375; https://doi.org/10.1590/S1518-8787.2016050006119
Carvalho MF, Pascom AR, Souza-Junior PR, Damacena GN, Szwarcwald CL. Utilization of medicines by the Brazilian population, 2003. Cad Saude Publica. 2005;21 Suppl:100-8. PMID: 16463001; https://doi.org/10.1590/s0102-311x2005000700011
Bertoldi AD, de Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2009;89(3):295-302. PMID: 18722031; https://doi.org/10.1016/j.healthpol.2008.07.001
Sans S, Paluzie G, Puig T, Balañá L, Balaguer-Vintró I. Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gac Sanit. 2002;16(2):121-30. https://doi.org/10.1016/S0213-9111(02)71643-9
Galvao TF, Silva MT, Gross R, Pereira MG. Medication use in adults living in Brasilia, Brazil: a cross-sectional, population-based study. Pharmacoepidemiol Drug Saf. 2014;23(5):507-14. PMID: 24520028; https://doi.org/10.1002/pds.3583
de Mesquita Mororó IMM, de Oliveira Santos EG, de Souza TA, de Almeida Medeiros A, Barbosa IR. Desigualdades no acesso a medicamentos no Brasil: um estudo de base populacional. Res Soc Dev. 2020;9(10):e5319108952-e. https://doi.org/10.33448/rsd-v9i10.8952
Paniz VM, Fassa AG, Facchini LA, et al. [Access to continuous-use medication among adults and the elderly in South and Northeast Brazil]. Cad Saude Publica. 2008;24(2):267-80. PMID: 18278273; https://doi.org/10.1590/s0102-311x2008000200005
Boing AC, Bertoldi AD, Boing AF, Bastos JL, Peres KG. [Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System]. Cad Saude Publica. 2013;29(4):691-701. PMID: 23568299.
Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55-64. PMID: 32799105; https://doi.org/10.1016/j.jad.2020.08.001
Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87. PMID: 32222812; https://doi.org/10.1007/s00134-020-06022-5
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. PMID: 32171062; https://doi.org/10.1016/S2213-2600(20)30116-8
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. PMID: 32091533; https://doi.org/10.1001/jama.2020.2648
Nicin L, Abplanalp WT, Mellentin H, et al. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Eur Heart J. 2020;41(19):1804-6. PMID: 32293672; https://doi.org/10.1093/eurheartj/ehaa311
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(25):e102. PMID: 32356626; https://doi.org/10.1056/NEJMoa2007621
Shaw, K. Colleges expand VPN capacity, conferencing to answer COVID-19. 2020. Available from: https://www.networkworld.com/article/3535415/colleges-expand-vpn-capacity-conferencing-to-answer-covid-19.html Accessed in 2021 (Mar 4).
Virtanen M, Honkonen T, Kivimaki M, et al. Work stress, mental health and antidepressant medication findings from the Health 2000 Study. J Affect Disord. 2007;98(3):189-97. PMID: 17182105; https://doi.org/10.1016/j.jad.2006.05.034
Rejeski WJ, Mihalko SL. Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci. 2001;56 Spec No 2:23-35. https://doi.org/10.1093/gerona/56.suppl_2.23
Bize R, Johnson JA, Plotnikoff RC. Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med. 2007;45(6):401-15. PMID: 17707498; https://doi.org/10.1016/j.ypmed.2007.07.017
Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531-42. PMID: 17707498; https://doi.org/10.1016/j.bbi.2020.05.048
Pavao AL, Werneck GL, Campos MR. [Self-rated health and the association with social and demographic factors, health behavior, and morbidity: a national health survey]. Cad Saude Publica. 2013;29(4):723-34. PMID: 23568302; https://doi.org/10.1590/S0102-311X2013000400010
Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912-20. PMID: 32112714; https://doi.org/10.1016/S0140-6736(20)30460-8
Zhou X, Snoswell CL, Harding LE, et al. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19. Telemed J E Health. 2020;26(4):377-9. PMID: 32202977; https://doi.org/10.1089/tmj.2020.0068
Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3(4):280-7. PMID: 29490333; https://doi.org/10.1001/jamacardio.2018.0022
Piche ME, Poirier P, Lemieux I, Despres JP. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018;61(2):103-13. PMID: 29964067; https://doi.org/10.1016/j.pcad.2018.06.004
Mavaddat N, Valderas JM, van der Linde R, Khaw KT, Kinmonth AL. Association of self-rated health with multimorbidity, chronic disease and psychosocial factors in a large middle-aged and older cohort from general practice: a cross-sectional study. BMC Fam Pract. 2014;15:185. PMID: 25421440; https://doi.org/10.1186/s12875-014-0185-6
Lorem GF, Schirmer H, Wang CE, Emaus N. Ageing and mental health: changes in self-reported health due to physical illness and mental health status with consecutive cross-sectional analyses. BMJ Open. 2017;7(1):e013629. PMID: 28100564; https://doi.org/10.1136/bmjopen-2016-013629
Rhodes RE, Janssen I, Bredin SSD, Warburton DER, Bauman A. Physical activity: Health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):942-75. PMID: 28554222; https://doi.org/10.1080/08870446.2017.1325486
Warburton DER, Bredin SSD. Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol. 2017;32(5):541-56. PMID: 28708630; https://doi.org/10.1097/HCO.0000000000000437
Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43. PMID: 18483608; https://doi.org/10.5688/aj720243
Manfreda KL, Bosnjak M, Berzelak J, Haas I, Vehovar V. Web surveys versus other survey modes: A meta-analysis comparing response rates. International journal of market research. 2008;50(1):79-104. https://doi.org/10.1177/147078530805000107
Salvador PTCdO, Alves KYA, Rodrigues CCFM. Online data collection strategies used in qualitative research of the health field: a scoping review. Rev Gaucha Enferm. 2020;41:e20190297. PMID: 32555956; https://doi.org/10.1590/1983-1447.2020.20190297
Asseray N, Ballereau F, Trombert-Paviot B, et al. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments. Drug Saf. 2013;36(12):1159-68. PMID: 24163273; https://doi.org/10.1007/s40264-013-0114-y
Sousa LAO, Fonteles MMF, Monteiro MP, et al. Prevalence and characteristics of adverse drug events in Brazil. Cad Saude Publica. 2018;34(4):e00040017. PMID: 29617479. https://doi.org/10.1590/0102-311X00040017
